| P50 | author | Michael P. Pignone | Q42908785 |
| | Robert S Sandler | Q87015965 |
| P2093 | author name string | Daniel E Jonas | |
| | Louise B Russell | |
| | Jon Chou | |
| P2860 | cites work | Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices | Q30815761 |
| | Collecting direct non-health care and time cost data: application to screening and diagnosis of cervical cancer | Q31043345 |
| | Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force | Q34740728 |
| | Screening of colorectal cancer | Q36287243 |
| | Colorectal cancer screening: health impact and cost effectiveness. | Q36507909 |
| | Costs incurred by patients undergoing advanced colorectal cancer therapy. A comparison of raltitrexed and fluorouracil plus folinic acid | Q38577938 |
| | Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey | Q40442425 |
| | Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? | Q40463586 |
| | A comparison of two methods for eliciting contingent valuations of colorectal cancer screening | Q42602924 |
| | Barriers to prenatal care among low-income women in New York City | Q42635240 |
| | Utilization of colonoscopy in the United States: results from a national consortium | Q43459096 |
| | Synergistic sedation with midazolam and propofol versus midazolam and pethidine in colonoscopies: a prospective, randomized study | Q44110686 |
| | Conscious analgesia/sedation with remifentanil and propofol versus total intravenous anesthesia with fentanyl, midazolam, and propofol for outpatient colonoscopy | Q44413088 |
| | Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP). | Q44555344 |
| | Benefits and costs of using HPV testing to screen for cervical cancer | Q44743125 |
| | Propofol versus midazolam/fentanyl for outpatient colonoscopy: administration by nurses supervised by endoscopists | Q44797491 |
| | Moderate level sedation during endoscopy: a prospective study using low-dose propofol, meperidine/fentanyl, and midazolam | Q44918405 |
| | Parental emotional and time costs predict compliance with respiratory syncytial virus prophylaxis | Q45176939 |
| | Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. | Q46013637 |
| | Colorectal cancer screening: clinical applications | Q46207970 |
| | Propofol alone titrated to deep sedation versus propofol in combination with opioids and/or benzodiazepines and titrated to moderate sedation for colonoscopy | Q48653899 |
| | Estimating time and travel costs incurred in clinic based screening: flexible sigmoidoscopy screening for colorectal cancer | Q50108640 |
| | Cost implications of routine mammography screening of women 50-69 years in the county of Funen, Denmark. | Q50567971 |
| | Travel distance as time price and the demand for mental health services. | Q52080281 |
| | Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research | Q56212513 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| | colonoscopy | Q840387 |
| P304 | page(s) | 2401-2410 | |
| P577 | publication date | 2007-06-29 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | Patient time requirements for screening colonoscopy. | |
| P478 | volume | 102 | |